Last reviewed · How we verify
Disease management of gastroesophageal reflux disease — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Disease management of gastroesophageal reflux disease (Disease management of gastroesophageal reflux disease) — US Department of Veterans Affairs.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Disease management of gastroesophageal reflux disease TARGET | Disease management of gastroesophageal reflux disease | US Department of Veterans Affairs | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Disease management of gastroesophageal reflux disease CI watch — RSS
- Disease management of gastroesophageal reflux disease CI watch — Atom
- Disease management of gastroesophageal reflux disease CI watch — JSON
- Disease management of gastroesophageal reflux disease alone — RSS
Cite this brief
Drug Landscape (2026). Disease management of gastroesophageal reflux disease — Competitive Intelligence Brief. https://druglandscape.com/ci/disease-management-of-gastroesophageal-reflux-disease. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab